Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR Inhaled Insulin in Type 1 Diabetes
NCT00127634Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Primary completion
- May 2008
- Modality
- Biologic
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of insulin human in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change in Hemoglobin A1c at 24 months. Started Jul 2005; status: completed.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00127634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127634.